Published: 27. June, 2025
Selected top 5 summarized questions from investors… Q&A Cessatech_June
Selected top 5 summarized questions from investors…
Related articles
Releases
27. August, 2026
CT001 ready for shipment to initial U.S. hospitals as launch activities commence
Initial U.S. commercial supply of CT001 now available for shipment Launch activities initiated with...
Releases
24. July, 2026
Proveca intends to request a re-examination of CHMP opinion for CT001/KemSu
See also the updated Q&A documentation related to the Release: Link The European Medicines...
Releases
12. June, 2026
Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet
Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children ...